LFCR
Lifecore Biomedical·NASDAQ
--
--(--)
--
--(--)
3.75 / 10
Netural
Analyst coverage is limited to one Buy rating with zero historical win rate, reflecting weak sentiment. Fund‑flow metrics are solid (7.5/10), showing inflows in Small and Large caps but overall negative trend. Mixed outlook.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-17
InstitutionBarrington Research
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for LFCR?
- LFCR holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.75/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
